-
Study aim
-
The effect of pulsatile and non-pulsatile flow on antioxidant markers during cardiopulmonary bypass in patients undergoing complex cardiac surgery will be investigated.
-
Design
-
The study has a control and intervention group, with parallel groups, blinded, randomized, phase 3 on 44 patients, and Excel software has been used for verification.
-
Settings and conduct
-
The study will be conducted in the operating room of the RHC. Patients are randomly divided into 2 groups: Group A:60 pulses per minute, Group B receives non-pulsatile flow. Blinding will be done unilaterally in such a way that the patients will be given explanations about the study, but the laboratory personnel And the sample collecting nurse will not know about the study.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:
Informed consent of the patient, Age range from 18 to 75 years, Elective patients who are candidates for complex surgery under CPB, Patients with 30% ≥ Ejection fraction, Not having a history of heart surgery, Not having liver failure in the form of ALT>40 units/L and AST>140 units/L, Not having impaired pulmonary function test before surgery in the form of forced expiratory volume in first second >65%, Not having creatinine level higher than 2 mg/dl, Not having hemoglobin level lower than 10 mg/dl, Not having active inflammation in the last month, Not having a history of taking antioxidant and anti-inflammatory drugs in the last month.
Exclusion criteria:
Aortic cross-clamp time less than 20 minutes, Pulse pressure less than 20 mmHg (in pulsating groups), Redo surgeries, Emergency surgeries
-
Intervention groups
-
The intervention group includes patients who will use pulsating flow with the same settings.The control group is the group in which patients will receive non-pulsatile flow.
-
Main outcome variables
-
Checking the level of MDA and TAC, the level of lactate, the level of liver enzymes